We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

At times, the cycling patent news cycle feels intense and a little relentless. A patent for exciting new components or some ...

Among the qualities a biotech company needs to be successful, being innovative is one of the most important. It's easy to understand why. Although drugs and vaccines benefit from patent protection for ...

More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

The long, strange trip to turn psychedelic drugs into approved medicines has hit a bad batch of developments in recent months ...

Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...

What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent ... but many patients with the debilitating disease continue to have ...

Shares in CureVac have plummeted after a German court ... seeking confirmation that Comirnaty does not infringe three CureVac patents, and the latter has since filed a counterclaim referencing ...

DRI Healthcare Trust ("DRI" or "the Trust") today announced its financial results for the quarter ended September 30, 2024. The Trust's third quarter 2024 financial statements and Management's ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...